Approved Projects
Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
---|---|---|---|---|---|
TransparentAI: High-Accuracy and Explainable Melanoma Classification System | Björn Friedrich | Carl von Ossietzky University, Medicine and Health Sciences, Department of Health Services Research, Division for Assistance Systems and Medical Device Technology | PLCO | Jul 15, 2024 | PLCO-1623 |
Transportation of Diagnostic Accuracy Measures to a New Target Population | Bing Li | Brown University | NLST | Sep 20, 2020 | NLST-712 |
Transporting a prediction model to a new cohort with a novel resampling method | Lei Song | George Washington University | NLST | Jan 9, 2024 | NLST-1182 |
Treatment effect in a proportional hazards model with instrumental variables | lorenzo tedesco | KU LEUVEN | HIPB | Dec 5, 2022 | HIPB-10 |
Treatment effect on the Survival Time of Lung Cancer Patients | Jing Zhou | Department of Family and Preventive Medicine | PLCO | Feb 27, 2020 | PLCO-591 |
Trichomonosis and prostate cancer risk in the Prostate, Lung, Colorectal & Ovarian Cancer Screening Trial | Siobhan Sutcliffe | Washington University | PLCO | Nov 9, 2009 | 2009-0556 |
Trustworthy Deep Learning Models for Calcification Assessment in Radiotherapy CT using NLST Data | Ivana Isgum | Amsterdam University Medical Center | NLST | Dec 4, 2024 | NLST-1362 |
TTFC and COPD in PLCO | Neil Caporaso | NCI, DCEG, GEB | PLCO | May 22, 2013 | PLCO-36 |
Tuberculosis and Scarring as Risk Factors for Lung Cancer | Eric Engels | NCI, DCEG, VEB | PLCO | Jul 1, 2006 | 2006-0078 |
Tumor early detection and prognosis | Hongtu Zhu | University of Texas MD Anderson Cancer Center | NLST | Nov 3, 2016 | NLST-254 |
Tumor infiltrating lymphocytes in colorectal cancer | Andrew Chan | Massachusetts General Hospital and Harvard Medical School | PLCO | Jun 16, 2016 | 2016-0012 |
Two-phase designs with failure time processes subject to non-susceptibility | Li Cheung | Li Chien Cheung | PLCO | May 30, 2023 | PLCO-1238 |
Type 1 and Type 2 ovarian cancer in the PLCO Trial | Keith Terada | University of Hawaii | PLCO | Nov 4, 2014 | PLCO-115 |
Types of Physical Activity, Sedentary Behavior and Risk of Cancer and Mortality: Pooled Analyses in the NCI Cohort Consortium | Steven Moore | National Cancer Institute | PLCO | Feb 26, 2024 | PLCO-1483 |
Ultra-Low-Dose Lung Nodule CT Surveillance Using Prior-Image-Based Reconstruction | Hao Zhang | Johns Hopkins University | NLST | Aug 3, 2017 | NLST-329 |
Ultraprocessed Food consumption and Dietary Antioxidant index and incident of Lung Cancer among adult population of US: Evidence from Prostate, Lung, Colorectal and Ovarian Cancers Trial | Tefera Mekonnen | The University of Adelaide | PLCO | May 23, 2022 | PLCO-982 |
Uncovering roles of polyunsaturated fatty acids (PUFA) in pancreatic cancer etiology: a gene-diet interaction study | Lang Wu | University of Hawaii at Manoa | PLCO | Jan 27, 2020 | PLCO-573 |
Underlying risk of developing and dying from lung cancer | Louise Henderson | University of North Carolina at Chapel Hill | NLST | May 16, 2024 | NLST-1248 |
Understanding comorbidities that contribute to drug response in ovarian cancer | Sara Cooper | HudsonAlpha Institute for Biotechnology | PLCO | Apr 13, 2018 | PLCO-362 |
Understanding Factors Related to Prostate, Lung, and Colorectal Cancer Screening Among African American Men | Marvella Ford | Medical University of South Carolina Hollings Cancer Center | PLCO | Jul 1, 2006 | 2006-0089 |